Mar 5 |
Earnings Scheduled For March 5, 2024
|
Feb 25 |
NeuroPace: Picking Up The Pace
|
Feb 23 |
20 Most Valuable Digital Health Companies In The US
|
Feb 2 |
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,848 Shares
|
Dec 30 |
NeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,402 Shares
|
Dec 21 |
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
|
Dec 19 |
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 7 |
NeuroPace: Making Strides In The Epilepsy Market
|
Dec 1 |
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
|
Nov 21 |
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
|